gdc

Web Exclusives

3 Ways to Protect Yourself from Skin Cancer
Skin Cancer
Skin cancer is the most common cancer in the United States. Other than sunscreen, many people are unaware of additional ways they can protect themselves and prevent skin cancer.
Health Insurance Is Key to Improved Equity in Cancer Care
Disparities in Cancer Care
Among the complex causes for the disparities in cancer outcomes, lacking or insufficient health insurance plays a major role. Good insurance coverage contributes to earlier diagnosis and improved treatment for patients with different types of cancers.
Oncology Social Workers: The Unsung Heroes of the Cancer Journey
Doctors and nurses are heroes for the care they provide, and researchers are heroes for the breakthrough treatments and medications they develop. Let us not overlook the incredible contributions of oncology social workers in the journey of a patient with cancer.
A Healthy Diet May Reduce the Risk of Cancer
Nutrition & Cancer
Based on current and evolving scientific evidence, the cancer prevention guidelines have been shifting from a nutrient-centric approach to a more holistic approach of diet that is characterized as dietary patterns.
Can You Get Pregnant If You Have Cervical Cancer?
Cervical Cancer
Cervical cancer during pregnancy can be successfully managed with a multidisciplinary treatment team and an individualized treatment strategy that optimizes maternal treatment while considering fetal safety.
FDA Approved Fyarro for Malignant Perivascular Epithelioid-Cell Tumor
FDA Approvals, News & Updates

On November 22, 2021, the FDA approved Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound); from Aadi Bioscience) for adults with locally advanced, unresectable or metastatic malignant perivascular epithelioid-cell tumor (PEComa), a rare type of mesenchymal tumors that can occur in any part of the body.

Jemperli a New Immunotherapy Approved for All Patients with dMMR Solid Tumors
FDA Approvals, News & UpdatesImmunotherapy
On August 17, 2021, the FDA accelerated the approval of Jemperli (dostarlimab-gxly; from GlaxoSmithKline) injection, an immunotherapy and a PD-1 inhibitor, for the treatment of all adults with recurrent (coming back) or advanced mismatch repair-deficient (dMMR) solid tumors, including lung cancer, that progressed during or after systemic therapy and for whom there are no satisfactory alternative treatment options.
Reasons for Optimism for Patients with Cancer Facing Another Winter with COVID-19
COVID-19 & Cancer
Although we are entering another winter with the ongoing prevalence of the coronavirus, we have come a long way since the initial outbreak. Here are some reasons for patients to be optimistic for the season.
Page 1 of 22
Results 1 - 10 of 220

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country
Gender
Race or Ethnicity
Profession or Role
Primary Interest